Description: Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Home Page: www.evelobio.com
EVLO Technical Analysis
620 Memorial Drive
Cambridge,
MA
02139
United States
Phone:
617 577 0300
Officers
| Name | Title |
|---|---|
| Dr. Balkrishan Gill Ph.D. | Pres, CEO & Director |
| Dr. Jonathan B. Zung Ph.D. | Chief Devel. Officer |
| Ms. Marella Thorell | CFO & Treasurer |
| Mr. Stephen J. Carriere | VP & Chief Accounting Officer |
| Dr. Chun Zhang Ph.D. | Chief Technical Operations & Quality Officer |
| Dr. Mark Bodmer Ph.D. | Chief Scientific Officer and Pres of R&D |
| Ms. Kendra Sweeney | Head of Investor Relations & Capital Markets |
| Ms. Jessica Cotrone | VP & Head of Communications |
| Ms. Leslie Wardwell-Scott Ph.D. | VP and Head of Corp. Devel. & Strategic Integration |
| Ms. Julie Carretero | Chief People Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 22.3128 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2018-05-09 |
| Fiscal Year End: | December |
| Full Time Employees: | 122 |